AGIOS PHARMACEUTICALS
Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.
AGIOS PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.agios.com
Total Employee:
101+
Status:
Active
Contact:
+1 617 649 8600
Total Funding:
775.82 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon HSTS IPv6 ReCAPTCHA Cloudflare Hosting ReCAPTCHA V2 Microsoft HSTS IncludeSubdomains PreLoad Ruby On Rails Token DigiCert SSL
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Fovea Pharmaceuticals
Fovea Pharmaceuticals is a French biopharmaceutical company that discovers and develops drugs for the treatment of ocular diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Quest PharmaTech
Quest PharmaTech is a pharmaceutical company that is developing antibody-based immunotherapeutic products for cancer.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Vion Pharmaceuticals Inc
Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies.
Current Advisors List
Advisor
Board_member
2007-12-01
Advisor
Board_member
2011-11-01
Board_member
2013-09-01
Board_member
Advisor
Advisor
Current Employees Featured
Sarah Gheuens Chief Medical Officer @ Agios Pharmaceuticals
Chief Medical Officer
2021-09-01
James Burns Chief Legal Officer @ Agios Pharmaceuticals
Chief Legal Officer
2002-01-01
Clive Patience Chief Technical Operations Officer @ Agios Pharmaceuticals
Chief Technical Operations Officer
2022-01-01
Tsveta Milanova Chief Commercial Officer (Jan 2023) @ Agios Pharmaceuticals
Chief Commercial Officer (Jan 2023)
2022-01-01
Shin Michael senior vice president, research & development @ Agios Pharmaceuticals
senior vice president, research & development
Bruce Car Chief Scientific Officer @ Agios Pharmaceuticals
Chief Scientific Officer
2020-01-01
Tak Mak Founders @ Agios Pharmaceuticals
Founders
Matthew Weinberg Director, Procurement @ Agios Pharmaceuticals
Director, Procurement
2015-01-01
Charlotte Newman Chief Business Officer @ Agios Pharmaceuticals
Chief Business Officer
Paul August Vice President, Genetically Defined Disease Biology @ Agios Pharmaceuticals
Vice President, Genetically Defined Disease Biology
2021-03-01
Founder
Stock Details
Investors List
Celgene
Celgene investment in Series C - Agios Pharmaceuticals
Flagship Pioneering
Flagship Pioneering investment in Series C - Agios Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Agios Pharmaceuticals
Third Rock Ventures
Third Rock Ventures investment in Series C - Agios Pharmaceuticals
Celgene
Celgene investment in Series B - Agios Pharmaceuticals
Flagship Pioneering
Flagship Pioneering investment in Series A - Agios Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Agios Pharmaceuticals
Third Rock Ventures
Third Rock Ventures investment in Series A - Agios Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-06 | Agios Appoints Tsveta Milanova as Chief Commercial Officer |
| 2022-07-13 | Agios appoints Brian Goff as new CEO |
Official Site Inspections
http://www.agios.com Semrush global rank: 2.93 M Semrush visits lastest month: 5.44 K
- Host name: 83.162.211.130.bc.googleusercontent.com
- IP address: 130.211.162.83
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Agios Pharmaceuticals"
Leadership - Agios
At Agios, leadership means building stronger bonds with colleagues, partners and patient communities and honoring each of their perspectives to make the process of developing life-changing treatments for patients with rare diseases more …See details»
About Us - Agios
Across our business, and beyond the walls of our organization, we foster connections that drive results and impact for patients. We share a set of values that promote contribution, …See details»
Agios Announces Evolution of Research Organization
May 16, 2022 Such forward-looking statements include those regarding Agios’ plans, strategies and expectations for the preclinical, clinical and commercial advancement of its drug …See details»
Corporate Governance – Agios Pharmaceuticals, Inc.
The Investor Relations website contains information about Agios Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Agios Pharmaceuticals - Wikipedia
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for …See details»
Agios Pharmaceuticals - LinkedIn
Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies ...See details»
Agios Pharmaceuticals - Organisation Profile - Lix
Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing …See details»
Growing Together…Development @ Agios - LinkedIn
Sep 20, 2017 Agios has scaled rapidly over the past 2+ years – growing from 100 people to more than 350 strong. One of our biggest priorities as a team is how to evolve and grow the company AND maintain the ...See details»
Agios - Sickle Cell Disease Association of America Inc.
Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class pyruvate kinase (PK) activator for adults …See details»
Inside Agios – Agios
As an organization that values and embraces differences, we’re continuously looking to improve the inclusivity of our workforce. This commitment is essential to our success and helps drive …See details»
Agios AB Company Profile | Stockholm, Stockholm, Sweden
Find company research, competitor information, contact details & financial data for Agios AB of Stockholm, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Agios Announces New Commercial Leadership Structure
Apr 2, 2019 Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular …See details»
Agios Pharmaceuticals Mission, Benefits, and Work Culture - Indeed
At Agios, our shared values and community-centric culture cultivate an environment that promotes collaboration, contribution, engagement and high regard for others’ points of view. This …See details»
Agios to Focus on Developing and Commercializing ... - Servier US
Dec 21, 2020 Agios Plans to Return at Least $1.2 Billion to Shareholders Following the Close of the Transaction, Anticipated in Q2 2021 – ... peers and advocates with the aim of entering into …See details»
Agios - Ownership and Business Overview - Mergr
Agios disclosed revenue of 27M USD for 2023 and 14M USD for 2022. How many employees does Agios have? Agios has 383 employees. What sector is Agios in? Agios is a life science …See details»
Agios Pharmaceuticals Management Team | Org Chart
Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing …See details»
Culture – Agios
At Agios, this deep sense of caring is what drives every person on our team and enables us to do meaningful work on behalf of people with rare diseases. It is central to our people …See details»
Agios - VentureRadar
" Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and genetically defined diseases through scientific …See details»
Welcome to myAgios Patient Support Services
Call 1‑877‑77‑AGIOS to speak to someone, or use the CNE Locator below. Find your CNE. Patient Support Managers Your Patient Support Manager (PSM) is your guide in helping you …See details»
What is Agios Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Agios Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Agios Pharmaceuticals.See details»